| Financial Year |
March 31 2023 |
| Monetary Funds |
392,471,338.43 |
| Held-for-trading Financial Assets |
13,629,726.18 |
| Notes Receivable |
100,000.00 |
| Accounts Receivable |
2,044,486,002.78 |
| Advances to Suppliers |
28,824,180.25 |
| Other Receivables |
30,918,118.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
238,123,252.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,683,181.57 |
| Other Current Assets |
136,019,447.75 |
| Total Current Assets |
3,245,630,250.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
165,721.61 |
| Long-term Equity Investment |
377,412,183.03 |
| Investment Properties |
19,223,718.30 |
| Fixed Assetes |
170,356,334.34 |
| Under-construction Projects |
3,062,864.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
588,369,057.70 |
| R&D expenses |
29,145,031.87 |
| Goodwill |
181,573,547.67 |
| Long-Term Deferred and Prepaid Expenses |
13,398,414.54 |
| Deferred Income Tax Assets |
72,268,563.31 |
| Other Non-Current Assets |
700,094,703.48 |
| Sub-Total of Non-Current Assets |
2,260,507,632.29 |
| Total Assets |
5,506,137,882.85 |
| Short-Term Loans |
1,023,575,259.02 |
| Trading Financial liabilities |
-- |
| Notes Payable |
268,853,659.18 |
| Accounts Payable |
777,972,599.58 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
30,913,793.30 |
| Taxes Payable |
346,430,311.24 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
18,469,145.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
39,160,233.60 |
| Other Current Liabilities |
11,143,209.15 |
| Sub-Total of Current Liabilities |
2,610,295,311.29 |
| Long-term Loans |
70,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
48,209,383.44 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
135,310,659.01 |
| Total Liabilities |
2,745,605,970.30 |
| Paid-In Capital(Or Share Stock) |
590,793,578.00 |
| Capital Surplus |
1,321,520,471.36 |
| Surplus Reserve |
96,490,260.70 |
| LESS:Treasury Stock |
101,158,836.44 |
| Undistributed Profits |
760,754,240.81 |
| Minority Stockholder's Interest |
92,132,198.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,668,399,714.43 |
| Owner's Equity（Stockholder's Equity） |
2,760,531,912.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,506,137,882.85 |
